.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The NEET-UG 2026 cancellation marks a significant turning point in the regulation of medical admissions in India. Consequently, the National Testing Agency (NTA) scrapped the examination conducted on May 3, 2026. This drastic measure emerged after investigators flagged serious concerns regarding the sanctity of the testing process. Furthermore, the Centre has officially handed the matter over to the Central Bureau of Investigation (CBI). This move seeks to address systemic vulnerabilities and restore public confidence in the national examination framework.
The NTA took the decision to cancel the test after reviewing critical inputs from various central agencies. Specifically, law enforcement findings suggested that the integrity of the examination process was compromised at multiple levels. Moreover, administrative glitches during the initial May session had already fueled frustration among students. For instance, power cuts in Indore and biometric errors caused significant delays. Therefore, the agency determined that the results from the May 3 session could not be upheld. This cancellation aims to ensure a fair and level playing field for all medical aspirants across the country.
The Central Government has mandated a comprehensive inquiry by the CBI to uncover the roots of the alleged malpractices. Additionally, the NTA has pledged full cooperation, offering all necessary records and assistance to the Bureau. This investigation will likely scrutinize the role of external intermediaries and potential security leaks within the testing centers. Similarly, the government is focusing on reforming the testing infrastructure to prevent future disruptions. Such steps are essential to protect the aspirations of over two million candidates who participate in this high-stakes exam annually.
Students who registered for the original May 2026 session do not need to submit a new application. Fortunately, their existing candidature data and chosen examination centers will remain valid for the upcoming re-test. The NTA will announce fresh dates and release revised admit cards through official channels shortly. Furthermore, the agency will not charge any additional examination fees for this process. Meanwhile, candidates are encouraged to continue their preparations and monitor the official NTA website for real-time updates regarding the examination schedule.
Q1: Why was the NEET-UG 2026 exam cancelled?
The NTA cancelled the exam due to serious concerns regarding its sanctity and integrity. Inputs from law enforcement agencies suggested that the examination process had been compromised, necessitating a full re-test to ensure fairness.
Q2: Do candidates need to pay fees again for the re-examination?
No, candidates do not need to pay any additional fees. The NTA stated that original registration details remain valid, and the re-test will be funded through the agency's internal resources.
Q3: Will the exam center change for the re-test?
The NTA intends to keep the chosen examination centers valid. However, candidates should verify their revised admit cards once they are released to confirm specific venue details and timings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NTA cancels NEET-UG 2026 due to integrity concerns. The Centre orders a CBI probe while fresh dates for the medical entrance exam will be announced soon....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
